Lilly’s push into pain research starting to pay off
In recent months, the drugmaker has won federal approval to sell a drug called Emgality for two conditions: migraine pain and cluster headaches.
Pharmaceutical
Articles
Report: Indiana opioid prescriptions down 35% since 2013
The American Medical Association Opioid Task Force 2019 Progress Report shows Indiana's reduction in opioid prescriptions from 2013 to 2018 is two percentage points higher than the national average.
Drugmakers sue Trump administration to halt advertising rule
Some of the biggest pharmaceutical companies, including Indianapolis-based Eli Lilly and Co., sued the Trump administration to try and block a rule that would force them to put the price of their drugs in television advertisements.
Q&A with Tiffany Benjamin: Lilly’s efforts more than simply a day of service
“Our central focus as a company is always to make lives better. … It’s a value that is core to every single employee who works here. So if we can have programs that reinforce that we are a company that is focused on making lives better, then we are doing something that connects to our mission and reminds our employees what really matters to us as a company.”
Lilly begins selling half-price version of popular Humalog insulin
The fast-acting insulin, which diabetics inject shortly before each meal, is used by about 700,000 Americans.
Indiana sues billionaire family behind maker of OxyContin
The Indiana lawsuit was filed Monday against eight members of Sackler family who own Connecticut-based drugmaker Purdue Pharma.
Drugmakers will have to reveal medication prices in TV ads
The Trump administration has finalized regulations that will require drug companies to disclose list prices of medications costing more than $35 for a month’s supply.
Pharmaceutical exec guilty of bribing doctors to push opioid
A pharmaceutical company founder accused of paying doctors millions in bribes to prescribe a highly addictive fentanyl spray was convicted Thursday in a case that exposed such marketing tactics as using a stripper-turned-sales-rep to give a physician a lap dance.
Former Pharmakon exec sentenced to five months for adulterating drugs, conspiracy
Caprice R. Bearden, the company’s former compliance officer, pleaded guilty in November to multiple criminal charges related to the sale of over-potent drugs. She later testified against her boss, who was convicted and awaits sentencing.
Drugmakers reveal list prices online after pressure from Trump
Indianapolis-based Eli Lilly and Co. was one of the first drug firms to begin sharing prices. Now, others are following suit.
Lilly bets billions on focus on cancer drugs
Long a leader in diabetes and neuroscience drugs, Eli Lilly and Co. is pushing hard and spending record sums to turbocharge its oncology business, potentially a huge growth area.
Bristol-Myers gets shareholder approval for $74B Celgene deal
Bristol-Myers Squibb Co. on Friday won a shareholder vote to approve its takeover of Celgene Corp., paving the way to close the largest pharmaceutical merger in history and create a cancer-drug giant.
Pharmacy owner found guilty of manufacturing over-potent drugs sold to hospitals
Paul Elmer, former owner and CEO of Pharmakon Pharmaceuticals in Noblesville, was convicted in federal court of nine counts of adulterating drugs and one count of conspiracy. He was acquitted of an additional count of obstruction of justice.
Ex-employees to testify exec knew drugs were dangerous
Paul Elmer, who founded Pharmakon 16 years ago and shut it down three years ago, faces charges of adulterating compounded drugs, conspiracy and obstructing a U.S. FDA investigation.
Amazon’s latest target is pharmacy disruption
As the online retailer has moved into new industries over the years, consumers have flocked to it and numerous traditional retailers have closed their doors, unable to compete.
Lilly, other insulin makers must face price-gouging lawsuit, judge rules
The suit accuses the companies of raising insulin sticker prices by more than 150 percent over five years, forcing diabetics to forgo the drug, take less insulin than needed or use expired versions
Indy startup Outpost Medicine draws in big money to develop drug therapies
For a startup that has raised an eye-popping $71 million in just three years, Outpost Medicine LLC likes to keep a low profile. The young company, which is developing drugs for urinary and gastrointestinal disorders, is headquartered in small, unmarked space at the Parkwood Crossing office complex on East 96th Street. It has issued only a […]
Trump targets drug middlemen with ‘devastating’ rebate overhaul
The Trump administration Thursday unveiled a plan to channel now-hidden prescription drug rebates directly to patients, saying it would bypass middlemen and lower prices for consumers.
Harvard study involving Anthem unit finds older insulins are both safe, cheaper
Increasingly, top researchers are questioning whether drugs such as Lantus from Sanofi, Levemir and Novolog from Novo Nordisk A/S, and Humalog from Eli Lilly and Co. are really needed for many patients.
Senators threaten to force drug execs to testify about prices
Sen. Ron Wyden, the ranking Democrat on the committee, singled out Humalog, an insulin made by Indianapolis-based Eli Lilly and Co, as a drug with unwarranted price hikes.